查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008438

弹性成像市场：按产品、组件、技术、最终用户和应用划分－2026-2032年全球市场预测

Elastography Imaging Market by Product, Component, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，弹性成像市场价值将达到 57 亿美元，到 2026 年将成长至 63.1 亿美元，到 2032 年将达到 115.8 亿美元，复合年增长率为 10.65%。

主要市场统计数据
基准年 2025 57亿美元
预计年份：2026年 63.1亿美元
预测年份 2032 115.8亿美元
复合年增长率 (%) 10.65%

全面概述弹性成像技术，拓展其临床效用，以及在临床环境中广泛应用的操作要求。

弹性成像技术正迅速成为多个临床领域中至关重要的诊断方法，使临床医生能够非侵入性地量化组织的机械特性，从而补充传统的解剖成像技术。磁振造影弹性成像（MR）和超音波弹性成像各有其独特的技术优势。 MR弹性成像可提供高解析度的全器官硬度图谱，是评估复杂肝臟和肿瘤的理想选择。而超音波弹性成像则可提供即时、经济高效的照护现场评估，并可无缝整合到常规临床工作流程中。随着人们对早期检测、监测治疗效果和微创分期的日益重视，这些互补的影像方式正将其临床效用从肝臟扩展到乳房、甲状腺和肌肉骨骼组织。

技术融合、数据驱动的影像解读和基于价值的医疗如何改变弹性成像领域的临床工作流程和供应商策略。

随着技术的成熟和临床需求的不断演变，弹性成像领域正经历着变革。剪切波生成、磁振造影弹性成像的运动编码策略以及韧体驱动的超音波换能器设计改进等技术的进步，显着提高了影像的保真度和可重复性。同时，先进分析技术和机器学习的融合，增强了特征提取和自动解读能力，降低了对操作者的依赖性，并加快了临床决策速度。这些技术突破与系统模组化的改进和软体主导的更新相辅相成，从而实现了演算法的改进和临床通讯协定的快速部署。

对修订后的定价结构对弹性成像硬体、软体和服务交付模式的多方面供应链和成本影响进行评估。

2025年实施的新关税措施对整个弹性成像供应链产生了累积影响，需要谨慎的策略性应对。感测器、运动驱动器和专用磁共振线圈等硬体组件对进口关税和运输成本的波动特别敏感，这可能会使原始设备製造商 (OEM) 和系统整合商的采购流程更加复杂。软体授权和基于云端的分析正面临着营运成本增加和跨境资讯服务可能受到限制的间接成本压力。包括现场校准和预防性保养的服务交付模式也可能受到物流成本上升和供应商部署策略变化的影响。

综合細項分析揭示了产品、组件、最终用户、技术和临床应用如何整合并决定部署优先顺序。

精细的细分观点有助于揭示临床价值和商业性机会在产品、组件、终端用户、技术和应用等维度上的交汇点。产品差异化主要体现在磁振造影弹性成像（MRE）和超音波弹性成像（UE）。 MRE有助于评估复杂的整体器官，而UE则可在病床和门诊进行即时、携带式评估。组件层面的趋势揭示了清晰的战略重点：硬体投资侧重于换能器和线圈的创新；软体投资侧重于分析功能和工作流程整合；服务侧重于培训、校准和临床支持，以确保成功部署。

美洲、欧洲、中东和非洲以及亚太地区的区域采用趋势和战略挑战，这些挑战正在影响商业化和临床整合。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的医疗技术应用路径、监管预期和商业化策略有显着影响。在美洲，先进的医疗基础设施、完善的报销体係以及高度集中的研究机构推动了磁振造影（MRI）和超音波弹性成像技术的早期应用，尤其是在肝病管理和肿瘤学应用方面。该地区的采购方通常要求提供可靠的检验研究、跨机构的互通性以及能够扩展到整个医院网路的服务交付模式。

决定硬体创新、分析平台和临床服务差异化领域领导地位的竞争性策略行动和伙伴关係模式。

弹性成像领域的竞争格局呈现出成熟医疗影像设备製造商、专业软体创新者以及专注于照护现场和人工智慧驱动解决方案的参与企业相互交锋的态势。关键策略倡议包括提升专有硬体效能，同时投资于能够将原始数据硬度指标转化为临床可用报告的分析平台。与学术机构和临床网络的合作对于循证医学证据的生成和指南的製定仍然至关重要，并有助于推动保守派相关人员接受该技术。

为供应商和医疗保健领导者提供实用策略指导，以增强产品模组化、证据产生、供应链弹性和在地化商业化。

产业领导者应推动一系列切实可行、以证据为基础的倡议，以确保临床意义和商业性韧性。首先，他们应优先考虑模组化产品架构，允许分阶段升级感测器技术、软体分析和云端服务，而无需对整个系统进行彻底改造，从而维护现有部署基础设施并支援更顺畅的资本规划。其次，他们应投资严格的临床验证项目，并针对优先适应症（例如肝纤维化分期和乳房病变特征分析）创建真实世界临床检验，以满足特定支付方和指南的要求。这些证据基础将在确保以价值为导向的医疗保健系统做出有利的采购决策方面发挥关键作用。

本文概述了用于创建弹性成像影像整合的调查方法，包括基于三角测量的定性研究和次要研究、专家检验，以及对分析严谨性的描述。

为确保证据基础的稳健性和说服力，本研究采用三角测量调查方法，结合专家访谈、一手质性研究和针对性的二手分析。关键资讯来源包括对临床专家、生物医学工程师、采购经理和服务人员的结构化访谈，从而深入了解设备性能、工作流程整合和部署障碍。此外，本观点还系统性地回顾了监管申报文件、同行评审的临床文献和公开的技术文檔，从而将技术能力和临床结果置于具体的背景中进行分析。

综合分析和策略展望，概述了将弹性成像技术的进步转化为可持续的临床应用和可衡量的医疗价值所必需的实际步骤。

弹性成像技术正处于策略转折点，技术进步、临床需求和商业策略必须协调一致，才能最大限度地发挥其在多种适应症中的潜力。磁振造影和超音波弹性成像技术的进步使得组织表征更加精准，而分析功能和互通软体的整合正在降低其常规临床应用的门槛。同时，价值链压力和不断变化的法规结构要求供应商和医疗机构采用稳健的营运模式，并投资于能够证明其临床和经济价值的证据。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：弹性成像市场：依产品划分

  • 磁振造影弹性成像
  • 超音波成像

第九章：弹性成像市场：依组件划分

  • 硬体
  • 服务
  • 软体

第十章：弹性成像市场：依技术划分

  • 剪切波弹性成像
  • 应变弹性成像

第十一章：弹性成像市场：依最终用户划分

  • 学术研究机构
  • 诊断影像中心
  • 医院

第十二章：弹性成像市场：依应用领域划分

  • 乳腺影像
  • 肝臟影像
  • 肌肉骨骼影像
  • 甲状腺影像

第十三章：弹性成像市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 弹性成像市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：弹性成像市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国弹性成像市场

第十七章：中国弹性成像市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced Instrumentations
  • BK Medical Holding Company, Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CHISON Medical Technologies Co., Ltd.
  • Clarius Mobile Health Corp.
  • Dawei Medical（Jiangsu）Corp., Ltd.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Jiangsu Aegean Technology Co.,Ltd
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Neusoft Medical Systems Co., Ltd.
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • Shimadzu Corporation
  • Siemens AG
  • SonoScape Medical Corp.
  • SternMed GmbH
  • SuperSonic Imagine SA
  • Toshiba Corporation
  • Zimmer MedizinSysteme GmbH
Product Code: MRR-C002B1C9967A

The Elastography Imaging Market was valued at USD 5.70 billion in 2025 and is projected to grow to USD 6.31 billion in 2026, with a CAGR of 10.65%, reaching USD 11.58 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.70 billion
Estimated Year [2026] USD 6.31 billion
Forecast Year [2032] USD 11.58 billion
CAGR (%) 10.65%

Comprehensive orientation to elastography imaging modalities, clinical utility expansion, and the operational prerequisites for widespread clinical adoption

Elastography imaging has emerged as a pivotal diagnostic modality across multiple clinical domains, enabling clinicians to quantify tissue mechanical properties noninvasively and thereby augment traditional anatomical imaging. Magnetic resonance elastography and ultrasound elastography each bring distinct technical strengths: MR elastography delivers high-resolution, whole-organ stiffness mapping well suited for complex hepatic and oncologic assessments, while ultrasound elastography provides real-time, cost-effective point-of-care evaluation that integrates seamlessly into routine clinical workflows. These complementary modalities are expanding clinical utility beyond the liver to include breast, thyroid, and musculoskeletal tissues, driven by an emphasis on early detection, therapy response monitoring, and minimally invasive disease staging.

Transitioning from research into routine practice requires alignment among clinical evidence, reimbursement frameworks, device interoperability, and operator training. Consequently, stakeholders across academia, diagnostic centers, and hospitals are now prioritizing comparative clinical trials, standardization of acquisition protocols, and integration of elastography outputs into electronic health records. As a result, technology developers and clinical leaders are converging on shared priorities: improving quantitative reproducibility, reducing time-to-result, and enhancing interpretive decision support through analytics. Taken together, these dynamics underscore an accelerating shift from niche research applications toward broader clinical adoption guided by evidence-based practice and operational efficiency.

How converging technology advances, data-driven interpretation, and value-based care are reshaping clinical workflows and vendor strategies in elastography

The elastography landscape is undergoing transformative shifts as technological maturation intersects with evolving clinical priorities. Advances in shear wave generation, motion-encoding strategies for MR elastography, and firmware-driven improvements in ultrasound transducer design have materially improved image fidelity and reproducibility. Concurrently, the integration of advanced analytics and machine learning is enhancing feature extraction and automated interpretation, which reduces operator dependence and accelerates clinical decision-making. These technical breakthroughs are complemented by improvements in system modularity and software-driven updates, enabling more rapid deployment of algorithmic enhancements and clinical protocols.

Beyond pure technology, the care delivery environment is shifting toward value-based models that reward diagnostic precision and reduced downstream costs. This is reshaping procurement preferences: healthcare providers are increasingly seeking solutions that demonstrate measurable clinical impact, predictable total cost of ownership, and robust service ecosystems. In parallel, regulatory pathways are evolving to accommodate software as a medical device and AI-enabled diagnostics, creating both opportunities and compliance obligations for vendors. Collectively, these forces are accelerating the transition from isolated research applications to integrated diagnostic pathways that prioritize longitudinal patient monitoring, cross-modality data fusion, and scalable service offerings.

Assessing the multifaceted supply chain and cost implications of altered tariff regimes on elastography hardware, software, and service delivery models

The introduction of new tariff measures in 2025 has produced cumulative effects across the elastography supply chain that merit careful strategic response. Hardware components such as transducers, motion drivers, and specialized magnetic resonance coils are particularly sensitive to changes in import duties and shipping costs, with the potential to increase procurement complexity for original equipment manufacturers and system integrators. Software licensing and cloud-based analytics face indirect cost pressures through increased operational expenses and potential constraints on cross-border data services. Service delivery models, including on-site calibration and preventive maintenance, may also be affected by higher logistics costs and altered vendor deployment strategies.

In response, stakeholders are adjusting sourcing strategies and contractual terms to preserve clinical access and margin structures. Some manufacturers are prioritizing localization of production or establishing alternative manufacturing footprints to mitigate tariff exposure. Others are shifting to subscription-based software agreements and remote diagnostics capabilities to offset higher hardware costs and maintain predictable revenue streams. For clinical providers, the tariffs underscore the importance of procurement agility, longer-term supplier partnerships, and careful life-cycle cost analysis. By adopting adaptive sourcing, enhanced inventory planning, and closer vendor collaboration, organizations can reduce disruption and maintain continuity of care without eroding clinical outcomes.

Integrated segmentation analysis revealing how product, component, end-user, technology, and clinical applications converge to define adoption priorities

A nuanced segmentation perspective helps clarify where clinical value and commercial opportunity intersect across product, component, end-user, technology, and application dimensions. Product differentiation is primarily expressed through magnetic resonance elastography, which serves complex whole-organ assessments, and ultrasound elastography, which provides real-time, portable evaluation at the bedside or in outpatient clinics. Component-level dynamics reveal distinct strategic emphases: hardware investments focus on transducer and coil innovation, software investments prioritize analytics and workflow integration, and services concentrate on training, calibration, and clinical support to ensure reliable adoption.

End-user profiles shape procurement criteria and utilization patterns. Academic research institutes emphasize experimental flexibility and integration with longitudinal studies, diagnostic imaging centers prioritize throughput and cost-effectiveness, and hospitals demand enterprise-grade interoperability and service coverage across multiple clinical departments. From a technology standpoint, shear wave elastography provides quantitative stiffness mapping with rapid acquisition, while strain elastography offers operator-applied compression techniques that are valuable in focal lesion characterization. Application areas further refine market needs: breast imaging requires high-resolution lesion differentiation and integration with biopsy workflows, liver imaging benefits from whole-organ fibrosis mapping and therapy monitoring, musculoskeletal imaging demands portability and dynamic assessment of soft-tissue biomechanics, and thyroid imaging calls for sensitive lesion characterization that can influence fine-needle aspiration decisions. Integrating these segmentation dimensions enables stakeholders to align product roadmaps, clinical validation strategies, and commercial models with clear end-user value propositions.

Regional adoption dynamics and strategic imperatives across the Americas, Europe Middle East and Africa, and Asia-Pacific that shape commercialization and clinical integration

Regional dynamics exert a profound influence on adoption pathways, regulatory expectations, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the combination of advanced healthcare infrastructure, established reimbursement frameworks, and a high concentration of research institutions has driven early adoption of both MR and ultrasound elastography, with a particular focus on liver disease management and oncologic applications. Buyers in this region commonly seek robust validation studies, enterprise interoperability, and service commitments that scale across hospital networks.

The Europe, Middle East & Africa landscape features heterogeneity in regulatory and reimbursement environments that favors flexible commercialization models and partnership-driven deployment. European health systems emphasize clinical guidelines and multicenter validation, which encourages collaboration between vendors and clinical consortia. Meanwhile, several Middle Eastern and African markets are prioritizing capacity building and diagnostic modernization, creating opportunities for tailored service contracts and mobile solutions.

Asia-Pacific is characterized by rapid clinical adoption, a substantial manufacturing presence for ultrasound components, and dynamic private healthcare sectors that accelerate commercialization of innovative diagnostics. Local regulatory reforms and expanding point-of-care networks have supported uptake in liver and breast imaging applications, while cost-sensitive procurement in many markets has heightened demand for scalable, modular solutions. Across regions, successful strategies combine localized evidence generation, adaptive pricing, and close collaboration with clinical champions to navigate diverse institutional priorities and regulatory regimes.

Competitive strategic behaviors and partnership models that determine leadership in hardware innovation, analytic platforms, and clinical service differentiation

Competitive dynamics in elastography are defined by a blend of established medical imaging manufacturers, specialized software innovators, and emerging entrants focused on point-of-care and AI-driven solutions. Key strategic plays include advancing proprietary hardware capabilities while simultaneously investing in analytic platforms that translate raw stiffness metrics into clinically actionable reports. Partnerships with academic centers and clinical networks remain a critical avenue for evidence generation and guideline development, supporting adoption among conservative procurement stakeholders.

In addition, companies that emphasize service excellence-through robust training programs, remote diagnostics, and lifecycle management-are differentiating on total cost of ownership and clinical uptime. Software vendors that prioritize open interfaces and standards-based integration with PACS and electronic health records facilitate smoother clinical workflows and accelerate buyer confidence. Strategic collaborations, licensing arrangements, and targeted acquisitions are typical routes for expanding intellectual property portfolios and accelerating time-to-market for new algorithms and device iterations. For clinical leaders, vendor selection increasingly reflects a balance between technical performance, evidence of clinical utility, and long-term service commitments that support scalability across care pathways.

Actionable strategic guidance for vendors and healthcare leaders to enhance product modularity, evidence generation, supply chain resilience, and regionally tailored commercialization

Industry leaders should pursue a set of pragmatic, evidence-driven actions to secure clinical relevance and commercial resilience. First, prioritize modular product architectures that allow incremental upgrades to transducer technology, software analytics, and cloud services without necessitating full system replacement, thereby preserving existing installed bases and supporting smoother capital planning. Second, invest in rigorous clinical validation programs and real-world evidence generation that address specific payer and guideline requirements for priority applications such as liver fibrosis staging and breast lesion characterization. This evidence base will be instrumental in securing favorable procurement decisions in health systems that emphasize value.

Third, strengthen supply chain resilience through diversification of manufacturing footprints, nearshoring options where feasible, and strategic inventory buffering to mitigate the operational impacts of tariff changes and logistics disruptions. Fourth, develop flexible commercial models that blend hardware sales with SaaS and managed service offerings to align vendor incentives with customer outcomes. Fifth, cultivate regional commercialization strategies that reflect local regulatory environments, reimbursement pathways, and clinical workflows, and establish deep partnerships with academic centers and key opinion leaders to accelerate adoption. Implementing these recommendations requires cross-functional coordination among R&D, regulatory, clinical affairs, and commercial teams to translate technological advantages into sustained clinical and financial outcomes.

Methodological overview describing triangulated qualitative and secondary research, expert validation, and analytical rigour used to produce the elastography imaging synthesis

This research synthesis was developed using a triangulated methodology that combines expert interviews, primary qualitative inquiry, and targeted secondary analysis to ensure a robust and defensible evidence base. Primary inputs included structured interviews with clinical specialists, biomedical engineers, procurement leads, and service professionals who provided granular insights into device performance, workflow integration, and adoption barriers. These perspectives were complemented by a systematic review of regulatory filings, peer-reviewed clinical literature, and publicly available technical documentation to contextualize technological capabilities and clinical outcomes.

Analytic processes incorporated cross-validation between qualitative insights and documented technology performance metrics, with particular attention to reproducibility and operator dependence. The methodology also included assessment of supply chain and policy developments through industry communications and trade publications, followed by scenario testing to understand operational implications. All findings were synthesized through iterative expert review to reconcile divergent views and surface practical recommendations. Limitations include the evolving nature of regulatory guidance and the rapid pace of algorithm development, which make ongoing validation and periodic updates essential for maintaining the research relevance.

Synthesis and strategic outlook outlining the practical steps needed to translate elastography technology advances into sustained clinical adoption and measurable healthcare value

Elastography imaging stands at a strategic inflection point where technical evolution, clinical needs, and commercial strategy must align to realize its full potential across multiple indications. Advances in MR and ultrasound elastography are enabling more precise tissue characterization, and the integration of analytics and interoperable software is lowering barriers to routine clinical use. At the same time, supply chain pressures and evolving regulatory frameworks require vendors and providers to adopt resilient operational models and to invest in evidence that demonstrates clinical and economic value.

Looking ahead, success will hinge on collaborative approaches that unite technology developers, clinical investigators, and health system decision-makers around common measurement standards, multicenter validation, and training programs that ensure consistent acquisition and interpretation. By prioritizing modular product design, flexible commercial models, and locally relevant evidence generation, stakeholders can accelerate adoption in both established and emerging healthcare markets. In short, the pathway to broader clinical impact is attainable through disciplined innovation, strategic partnerships, and sustained attention to real-world utility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Elastography Imaging Market, by Product

  • 8.1. Magnetic Resonance Elastography
  • 8.2. Ultrasound Elastography

9. Elastography Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
  • 9.3. Software

10. Elastography Imaging Market, by Technology

  • 10.1. Shear Wave Elastography
  • 10.2. Strain Elastography

11. Elastography Imaging Market, by End User

  • 11.1. Academic Research Institutes
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals

12. Elastography Imaging Market, by Application

  • 12.1. Breast Imaging
  • 12.2. Liver Imaging
  • 12.3. Musculoskeletal Imaging
  • 12.4. Thyroid Imaging

13. Elastography Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Elastography Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Elastography Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Elastography Imaging Market

17. China Elastography Imaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Advanced Instrumentations
  • 18.6. BK Medical Holding Company, Inc.
  • 18.7. Boston Scientific Corporation
  • 18.8. Canon Medical Systems Corporation
  • 18.9. CHISON Medical Technologies Co., Ltd.
  • 18.10. Clarius Mobile Health Corp.
  • 18.11. Dawei Medical (Jiangsu) Corp., Ltd.
  • 18.12. Esaote SpA
  • 18.13. Fujifilm Holdings Corporation
  • 18.14. GE HealthCare Technologies Inc.
  • 18.15. Hitachi, Ltd.
  • 18.16. Jiangsu Aegean Technology Co.,Ltd
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Mindray Medical International Limited
  • 18.19. Neusoft Medical Systems Co., Ltd.
  • 18.20. Resoundant, Inc.
  • 18.21. Samsung Medison Co., Ltd.
  • 18.22. Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • 18.23. Shimadzu Corporation
  • 18.24. Siemens AG
  • 18.25. SonoScape Medical Corp.
  • 18.26. SternMed GmbH
  • 18.27. SuperSonic Imagine SA
  • 18.28. Toshiba Corporation
  • 18.29. Zimmer MedizinSysteme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELASTOGRAPHY IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ELASTOGRAPHY IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)